In addition, the level of SNHG1 was markedly upregulated in patients with lymph node metastasis (N1/2) group, compared with patients without lymph node metastasis (N0) group (Figure 1C). The gene discussed is SNHG1; the disease is metastatic malignant neoplasm in the lymph nodes.